INTRODUCTION
Obesity is a widespread public health problem afflicting many countries around the world. Although obesity conveys a clear unfavourable prognosis for morbidity and mortality in the general population, this association seems blunted in some chronic conditions with obese individuals presenting with a survival advantage over their counterparts, a phenomenon termed the 'obesity paradox' or 'reverse epidemiology'.
The obesity paradox is a controversial concept that can be attributed to methodological limitations of the studies wherein it has been observed. One of the criticisms is the use of anthropometrics estimates such as BMI to define obesity. Body weight and BMI do not depict the different proportions of lean versus adipose tissues (i.e. body composition), confounding health consequences for morbidity and mortality, especially in clinical scenarios [1 & ]. This review will describe the past year's evidence on the obesity paradox phenomenon, primarily focusing on the role of abnormal body composition phenotypes in explaining the controversies observed in the literature.
(2) collider stratification bias, a type of selection bias wherein the conditioning on a variable affected by exposure shares common causes with the outcome producing a spurious protective prognostic effect of obesity [5] ; (3) observational and cross-sectional study designs; and (4) inadequacy of BMI as an obesity classifier.
As discussed by Heymsfield and Cefalu [6] , the use of BMI as a health risk phenotype has several limitations. BMI accounts for about two-thirds of the between-individual variability in total adiposity. In spite of the high correlation of BMI with adiposity, a two to three-fold variation in visceral adiposity is observed at any given BMI, illustrating how BMI is not a specific index of abnormal fat accumulation. Therefore, among equally overweight individuals, differences in overall quantity and distribution of adipose tissue, muscularity, nutritional status disease risk factors (disease severity and comorbidities), age, race and sex may explain the greater risk for shorter survival [4, 6] .
Of our particular interest, and the focus of this review, is the use of BMI to diagnose obesity in view of the variability in body composition phenotypes of the contemporary population. As we will discuss next, BMI does not accurately depict different components of body composition and is therefore unable to predict the prognostic effect of individual tissues, Fig. 1 .
BODY COMPOSITION PHENOYPES: DEMYSTIFYING THE OBESITY PARADOX?
Higher BMI is generally found to be associated with greater muscle mass and strength. This is because fat
KEY POINTS
Obesity paradox is a topic of intense interest yet with notably contradictory findings.
Shortcomings associated with these contradictory findings may be explained by the inadequacy of BMI as an obesity classifier.
Variability in body composition phenotypes (i.e. adipose versus muscle tissues) of contemporary population indicates different nutritional status even in individuals with identical BMI.
The use of body composition analysis indicates that excess adipose tissue has no protective effect in the presence of low muscle mass.
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Obese with high lean mass FIGURE 1. Illustration scheme of potential differences in body composition in individuals with identical BMI (grey represents fat mass and black represents lean mass).
and lean masses are expected to grow in harmony with each other. Although this may be true for the majority of individuals, the assessment of in-vivo body composition has highlighted that this is not a ubiquitous phenomenon. High body weight (hence BMI) and fat mass can coexist with obesity, a syndrome known as 'sarcopenic obesity'. In fact, the concurrent appearance of low muscle and high adipose tissue can occur at any given BMI across the age spectrum [7, 8] . We used North-American population-cohort data to illustrate the variability in body composition phenotypes at different ages and across the BMI categories. With our proposed classification criteria to define abnormal body composition, we reported that normal-weight individuals could present with diverse body composition phenotypes such as high adiposity-high muscularity, low adiposity-low muscularity or even high adiposity-low muscularity (i.e. analogous to sarcopenic obesity). Each of these phenotypes is likely to be associated with diverse nutritional status. Oreopoulos et al. [9] reported that BMI misclassified 41% of body fat status in patients with chronic heart failure. A higher muscularity and/or lower adiposity were independently associated with advantageous prognostic factors in these patients. Similar findings were more recently confirmed in patients with cancer: those with excess fat mass were misclassified as overweight or even normal weight according to BMI criteria [10 & ]. Such misclassification may explain the controversial results of the obesity paradox reported in studies using BMI as a classification criterion for obesity. These findings highlight the need for further studies investigating the obesity paradox phenomenon in the context of body composition assessment.
THE PAST YEAR EVIDENCE AT A GLANCE
The obesity paradox may certainly be considered a topic of high interest in the scientific community with a total of 71 published articles in the past year alone. Within this time frame, we found 25 review articles, four meta-analyses and 42 original articles discussing this phenomenon. Out of the original articles (N ¼ 42), 31 used only BMI to classify obesity, whereas seven used a surrogate assessment of body composition (e.g. waist or hip circumference, skinfold thickness) and four used a direct assessment of body composition.
Studies using BMI as the sole indicator of obesity Table 1 depicts a summary of the studies in which only BMI was used to define obesity [3, 5, .
Patient cohorts included various forms of cardiovascular diseases, investigated in the majority of the studies (N ¼ 21/31). Other patient cohorts included those with rheumatoid arthritis, peptic ulcer, peritonitis and sepsis, diabetes mellitus type 2, dementia, COPD, lung resection, mechanical ventilation and a cohort of nondiseased individuals. Table 1 summarizes that the obesity paradox (higher BMI associated with better prognosis) was reported in 13 out of 31 studies. Out of these, two studies observed this association in overweight but not obese individuals [14, 18] ; one observed it in men but not women [27] ; one in short but not long-term outcomes (mortality rate) [34] , and one in some outcomes (myocardial infarction and septicemia) but not survival [26] . Mixed findings were reported in two studies when patients were stratified by ventilated versus nonventilated group (only the former showing obesity paradox) [30] and low versus high cardiorespiratory fitness [13] , with only the former showing the paradox. The remaining (and majority) of the studies failed to demonstrate a prognostic advantage to having excess body weight (Table 1) .
The four meta-analyses reported the following: Sharma et al. [40] investigated the relationship of BMI with all-cause and cardiovascular mortality and hospitalization in six studies of patients with chronic heart failure. The authors concluded that risk for cardiovascular mortality and incidence of hospitalization was lowest in overweight patients but found no differences in all-cause mortality. Severe obesity was associated with poor overall cardiovascular outcomes, suggesting that apparent effect of adiposity does not occur at the extreme levels of obesity. In a separate meta-analysis of 36 studies, the same group investigated the obesity paradox after coronary artery disease revascularization procedures [41] . When looking at total mortality, cardiovascular mortality and myocardial infarction, only cardiovascular mortality was found to be lower in overweight patients. In both studies, detailed data on cardiovascular risk factors, severity/stage of disease or unintentional weight loss were not available, which does not rule out the possibility of residual confounding effects in the reported results.
Niedziela et al. [42] reported the relationship between BMI and total mortality in 26 studies of patients after acute coronary syndrome. The authors concluded that overweight, obese and severely obese patients presented with lower mortality than those with normal BMI. The authors noted that although obesity was associated with comorbidities, these patients were younger and had less bleeding complications, which could have influenced survival. Although this study used body composition terminology, the calculations were derived from BMI, age and sex.
Ahmadi et al. [43] investigated the obesity paradox in kidney transplant recipients in four studies, reporting a higher mortality in obese patients using pretransplantation BMI. Notably, all of these metaanalysis studies reported a higher risk of shorter survival among underweight patients. Ahmadi et al. [43] highlighted that unlike obesity, being underweight consistently predicted survival. Therefore, there are paradoxical or differing results suggesting that the presence of obesity paradox is unlikely in such a scenario [43] .
Using data from 89 studies with a total of 1 300 794 patients wherein risk estimates were provided for short and long-term mortality on cardiovascular events, Wang et al. [44] reported a J-shaped relationship between mortality and BMI in patients with coronary artery disease. Underweight patients presented with the highest risk and the overweight and obese with the lowest. Nonetheless, inconsistent findings were reported when the long-term data were evaluated. The long-term inverse relationship between BMI and mortality was attenuated, disappearing after 5 years of follow-up. Grades II and III obesity were associated with lower risk of short-term mortality but higher risk after 5 years of follow-up.
Studies using surrogate assessments of body composition
Additional anthropometric measurements such as waist and/or hip circumference, skinfold thickness measurements and circumferences were used in seven studies, in which three reported the obesity paradox (one observing it in men only) and the remaining disproving such phenomenon (Table 2 ) [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] . Using an inception cohort of adults with diabetes, Bozorgmanesh et al. [45] highlighted the need of adjusting for a measure of central adiposity when investigating the effect of obesity and mortality. The lack of a value for waist circumference would have led to an overestimation of the mortality associated with an increased BMI in their database of newly diagnosed patients with diabetes. The authors noted that there is a 'BMI-paradox', which is not a sufficient marker of obesity.
The need for further measurements of nutritional assessment when investigating the obesity paradox was highlighted in the study by Gastelurrutinia et al. [47 && ]. In patients with heart failure, nutritional status (undernourished) was an independent prognostic factor above and beyond BMI and percentage body fat (calculated using surrogate tools). Therefore, in this study, BMI masked true nutritional status.
Using arm circumferences and skinfold measurements of patients receiving elective surgery, Rodriguez-Garcia et al. [49] found no differences in nosocomial infection and length of hospital stay comparing obese and nonobese patients; nonetheless, the authors have not controlled for confounding variables; only bivariate analysis was conducted. In patients with acute coronary syndrome, Shehab et al. [50] showed that in-hospital and peri-hospital mortality was not associated with weight, BMI or waist circumference.
Studies using body composition assessments
There is a clear need for further body composition assessment studies to elucidate the contradictory evidence on the obesity paradox phenomenon as only four have been published in the past year. Among these, the methodologies utilized were computed tomography (CT, two studies), dual-energy X-ray absorptiometry (DXA) or bioelectrical impedance analysis (BIA), Table 2 .
In 72 patients with COPD, survival was not different between higher versus lower BMI patients (although a trend towards longer survival was observed in those with higher BMI) [52 && ]. Overweight and obese patients had better lung function, exercise capacity and larger muscle cross-sectional area than those with normal BMI. These variables were able to confound the trend of improved survival in those with excess BMI.
An interesting study in older adults with type 2 diabetes; Murphy et al. [54 && ] used CT-assessed body composition and functional assessments to test the association between these variables and mortality. Using multivariate analysis adjusted for demographic and diabetes-risk factors, they reported higher risk in normal-weight patients than overweight ones. The authors further performed a mediation analysis to test if adipose tissue, muscle size and physical function would affect the associations between BMI and mortality. From this analysis, thigh muscle size mediated 46% of the effect of the higher risk found in normal-weight patients. When comparing four groups: overweight/normal weight and high/low muscle (according to the respective sex-specific median), the authors concluded that being overweight was only protective in patients with high muscle mass and that the highest mortality was found in the two low muscle mass groups (either in patients with normal weight or overweight). These results are similar to what has been reported in cancer patients [10 & ]. Using BIA to assess body composition, Gonzalez et al. [10 & ] reported that the obesity paradox was only present in cancer patients when obesity was defined by BMI. BMI was not able to identify the majority of patients with excess fat mass and low muscle mass was an independent risk factor for higher mortality. Excess fat mass had no protective effect in the presence of low muscle mass and the shorter survival time was indeed observed in the sarcopenic obesity group. Two studies noted the obesity paradox using direct assessment of body composition. In the study by Hong et al. [53] , higher visceral adiposity assessed by CT scan and not BIA-assessed total fat mass was associated with reduced all-cause mortality in elderly Asian individuals (mean age 76 years). All-cause mortality was lowest within the highest and third BMI and visceral adiposity quartiles, respectively. Furthermore, visceral adiposity was a marker for mortality in a U-shaped pattern. Interestingly and unfortunately, the authors have not explored the effect of fat free mass (and hence muscle mass) in their model, even though that was assessed by BIA. CT-assessed muscle mass was also not evaluated. As the authors discussed, muscle mass is an important variable that can explain their findings. Finally, the study by Perna et al. [55] examines the association among low muscle mass, adiposity and metabolic markers in Italian older individuals. In a complex statistical analysis called canonical correlation analysis and structural equation modelling, individual scores of metabolic profile were created and correlated with muscle mass. The authors noted a negative association between sarcopenia severity and adiposity/metabolic profile, indicating a protective effect of adiposity on muscle loss. Therefore, although their results confirmed the obesity paradox, an increase of adiposity and levels of metabolic parameters were protective in respect to muscle loss [55] .
CONCLUSION
A perpetuation of the contradictory findings related to the obesity paradox is highlighted in this review, independent of the definition of obesity being solely based on BMI, surrogate or direct assessments of body composition.
There is enough evidence in the literature highlighting the value of body composition assessment to evaluate and predict nutritional status, and emerging evidence that body composition phenotypes may demystify the obesity paradox phenomenon. Nonetheless, less than 10% (four out of 42) of the original articles published in the past 12 months included a direct assessment of body composition and, among these, a full description of compartments (e.g. muscle mass) was not conducted/explored.
In view of the body composition variability of patients with identical BMI, particularly in clinical populations, it is unreasonable to rely solely on this index as a marker to identify obesity. Furthermore, differences in fluid shifts that may occur in these clinical conditions may also impact the accuracy of BMI [47 && ], potentially overestimating BMI measurements (e.g. heart failure patients).
The use of sophisticated body composition assessment tools is still limited (especially in epidemiological settings). Notwithstanding, it is unlikely that we will substantially advance our knowledge without the use of this science. As we have previously discussed [1 & ,7], Hippocrates could have measured body weight and BMI. We are in an era in which sophisticated tools are needed and in line with any other evolving field of health-related research.
If body composition phenotypes can indeed elucidate the dichotomous relationship between BMI and prognostication in a variety of clinical and nonclinical conditions, the need is urgent for such a research approach. The consequences of a potential insubstantial obesity paradox are mixed messages advising individuals to become obese in the hopes of improving outcomes. Finally, adjusting for important confounding bias originating from each specific condition under study is also important and potentially mediators of the risk factor associated with obesity.
